Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15823-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15823-1-AP, RRID:AB_2272584
- Product name
- UBASH3A-Specific antibody
- Antibody type
- Polyclonal
- Description
- UBASH3A-Specific antibody (Cat. #15823-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references FCRL3 is an immunoregulatory receptor that restrains the activation of human memory T lymphocytes.
FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression.
UBASH3A Interacts with PTPN22 to Regulate IL2 Expression and Risk for Type 1 Diabetes.
STS1 and STS2 Phosphatase Inhibitor Baicalein Enhances the Expansion of Hematopoietic and Progenitor Stem Cells and Alleviates 5-Fluorouracil-Induced Myelosuppression.
TCR signaling promotes formation of an STS1-Cbl-b complex with pH-sensitive phosphatase activity that suppresses T cell function in acidic environments.
Inhibition of T cell activation and function by the adaptor protein CIN85.
UBASH3A Regulates the Synthesis and Dynamics of TCR-CD3 Complexes.
UBASH3A Mediates Risk for Type 1 Diabetes Through Inhibition of T-Cell Receptor-Induced NF-κB Signaling.
Bianchi N, Foli E, Mostanfar M, Marzi R, Spinella MC, Polletti S, Pecoraro M, Cassotta A, Thakur R, Jarrossay D, Sallusto F, Natoli G, Monticelli S
The Journal of experimental medicine 2026 Jan 5;223(1)
The Journal of experimental medicine 2026 Jan 5;223(1)
FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression.
Wang J, Wang C, Hu A, Yu K, Kuang Y, Gajendran B, Zacksenhaus E, Sample KM, Xiao X, Liu W, Ben-David Y
BMC cancer 2024 Mar 9;24(1):326
BMC cancer 2024 Mar 9;24(1):326
UBASH3A Interacts with PTPN22 to Regulate IL2 Expression and Risk for Type 1 Diabetes.
Newman JRB, Concannon P, Ge Y
International journal of molecular sciences 2023 May 12;24(10)
International journal of molecular sciences 2023 May 12;24(10)
STS1 and STS2 Phosphatase Inhibitor Baicalein Enhances the Expansion of Hematopoietic and Progenitor Stem Cells and Alleviates 5-Fluorouracil-Induced Myelosuppression.
Li N, Wang Y, Wang A, Zhang J, Jia C, Yu C, Song Z, Wang S, Liu L, Yi J, Bao Y, Huang Y, Sun L
International journal of molecular sciences 2023 Feb 3;24(3)
International journal of molecular sciences 2023 Feb 3;24(3)
TCR signaling promotes formation of an STS1-Cbl-b complex with pH-sensitive phosphatase activity that suppresses T cell function in acidic environments.
Tsai YL, Arias-Badia M, Kadlecek TA, Lwin YM, Srinath A, Shah NH, Wang ZE, Barber D, Kuriyan J, Fong L, Weiss A
Immunity 2023 Dec 12;56(12):2682-2698.e9
Immunity 2023 Dec 12;56(12):2682-2698.e9
Inhibition of T cell activation and function by the adaptor protein CIN85.
Kong MS, Hashimoto-Tane A, Kawashima Y, Sakuma M, Yokosuka T, Kometani K, Onishi R, Carpino N, Ohara O, Kurosaki T, Phua KK, Saito T
Science signaling 2019 Feb 5;12(567)
Science signaling 2019 Feb 5;12(567)
UBASH3A Regulates the Synthesis and Dynamics of TCR-CD3 Complexes.
Ge Y, Paisie TK, Chen S, Concannon P
Journal of immunology (Baltimore, Md. : 1950) 2019 Dec 1;203(11):2827-2836
Journal of immunology (Baltimore, Md. : 1950) 2019 Dec 1;203(11):2827-2836
UBASH3A Mediates Risk for Type 1 Diabetes Through Inhibition of T-Cell Receptor-Induced NF-κB Signaling.
Ge Y, Paisie TK, Newman JRB, McIntyre LM, Concannon P
Diabetes 2017 Jul;66(7):2033-2043
Diabetes 2017 Jul;66(7):2033-2043
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- human spleen tissue were subjected to SDS PAGE followed by western blot with 15823-1-AP(UBASH3A-Specific antibody) at dilution of 1:400
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunofluorescent analysis of HepG2 cells, using UBASH3A antibody 15823-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line